Questions About Funding, Text Of Tufts Study On Drug Costs 03/02/2015 by Intellectual Property Watch Leave a Comment The Union for Affordable Cancer Treatment has sent a letter to the author of a much-noted Tufts University (US) study that found high development costs for medicines, with copies to the university administration. The letter requests transparency on the funding of the study and the press conference announcing the results, as well as copies of the study itself, which the group says was not made public, along with details to justify the result.
WHO Board Recommends Extension Of Plan For Health Innovation, IP 03/02/2015 by William New and Catherine Saez, Intellectual Property Watch 1 Comment The World Health Organization Executive Board this week recommended the extension of an important strategy and plan of action on health, IP and innovation. It also set out steps to resolve questions over evaluation and review of the strategy and plan of action before the annual World Health Assembly in May.
WHO Sets Path For Completing Rules Of Engagement With Industry, Foundations 02/02/2015 by William New, Intellectual Property Watch Leave a Comment The World Health Organization Executive Board has set a way forward from now to the annual May World Health Assembly for addressing the sensitive issue of drafting a framework for engagement with “non-state actors,” such as industry, foundations, academics and other non-governmental stakeholders.
WHO Still Finding Its Way On Financing R&D For Diseases Affecting Poor Countries 02/02/2015 by Catherine Saez, Intellectual Property Watch Leave a Comment In search of sustainable innovation models for cures for diseases affecting primarily developing countries, with the Ebola epidemic as a new reminder of the necessity and urgency of the matter, the World Health Organization had tasked an expert working group with the search for solutions. Last week, the WHO Executive Board took note of the progress made so far.
The Latest News In Intellectual Property From ANEPI Ecuador 02/02/2015 by Intellectual Property Watch, Intellectual Property Watch Leave a Comment Welcome to (ANEPI), the first Intellectual Property News Agency of Ecuador. The Agencia de Noticias Especializada en Propiedad Intelectual (ANEPI) publishes news, analysis, interviews, feature articles, a weekly update and more on Ecuador and the region, at http://www.anepi.ec. Articles are primarily in Spanish with some translation. Bienvenido a (ANEPI), La Primera Agencia de Noticias de […]
Circuit Courts Open As Satellites Of China’s Supreme People’s Court 01/02/2015 by Mingjiang Liu for Intellectual Property Watch Leave a Comment After long preparations, the Second Circuit Court of China’s Supreme People’s Court was officially instituted in Shenyang city, Liaoning province in northeast China on 31 January. Qiang Zhou, president and chief judge of China’s Supreme People’s Court, attended and addressed the nameplate unveiling ceremony of the Second Circuit Court.
Special Report: Will India Bend To US Pressure On IP Rights? 31/01/2015 by Patralekha Chatterjee for Intellectual Property Watch 5 Comments It is no secret that the United States has been scaling up pressure on India to adopt intellectual property measures similar to those common in the United States and the European Union. But to what extent does India’s new government led by the business-friendly Narendra Modi see eye to eye with US official position? Can India, the “pharmacy of the world”, resolve the friction between pharmaceutical patents and access to affordable medicines without putting off foreign investors? The vitriolic and polarising debate surrounding these questions has got a fresh lease of life following US President Barack Obama’s landmark three-day visit to India this week. While Indian and American business moguls are bullish about the future, Indian generic drug-makers as well as health activists within and outside India are deeply anxious about the shape of things to come
IP Rights Must Remain Distinct From Fake Medicines Policy At WHO, Members Warn 30/01/2015 by Catherine Saez, Intellectual Property Watch 1 Comment Intellectual property issues emerged at the World Health Organization Executive Board today as members discussed fake and substandard medicines, with some countries saying that the fight against such medicines should not serve as a pretext to enforce intellectual property rights and prevent access to safe generic medicines.
Antimicrobial Resistance, Budget, Reform Raise Debate At WHO Executive Board 30/01/2015 by Catherine Saez, Intellectual Property Watch Leave a Comment The World Health Organization Executive Board this week has addressed the relationship between the UN agency and its funders and lobbyists, examined the budget for the next biennium, and looked at the issue of the growing resistance of bacteria to antibiotics. Image Credits: Flickr – NIAID
Geneva Forecast On Internet Governance: 2015 Expected To Be A Decisive Year 30/01/2015 by James Cote for Intellectual Property Watch Leave a Comment A Geneva expert has offered his view on the top internet governance issues likely to come up in 2015. These include: cybersecurity, privacy, internet neutrality, and the proposed transition of control over a key underlying aspect of the internet.